Search

Memorial Sloan Kettering Cancer Center (MSK) announced today that physician-scientist Karuna Ganesh, MD, PhD, has been awarded a Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems in cancer research. Dr. Ganesh is part of an international team focused on developing new ways to “rewire” cancer cells and prevent treatment resistance in colorectal cancer, one of the leading causes of cancer-related deaths worldwide, and with rates rising among adults under 50.

… Wednesday, March 4, 2026 Memorial Sloan Kettering Cancer Center (MSK)  announced today that physician-scientist  Karuna Ganesh, MD, PhD, has been awarded a  Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems

A Q&A with Jaap-Jan Boelens, MD, PhD, Chief of the Pediatric Transplant and Cellular Therapy Service at MSK.

… Monday, December 9, 2024 MSK is the first hospital in New York City to offer gene therapy through its pediatric cancer program MSK Kids. Exagamglogene autotemcel (exa-cel) (Casgevy®) is a gene therapy for treating sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises

Cancer vaccines that use messenger RNA (mRNA) technology are an exciting new approach to develop immunotherapies for cancers with poor prognoses, such as pancreatic cancer.

… Wednesday, January 5, 2022 Cancer vaccines that use messenger RNA (mRNA) technology are an exciting new approach to develop immunotherapies for cancers with poor prognoses, such as pancreatic cancer. There is a tremendous, urgent need for new treatments for pancreatic cancer. Although the discovery of

Learn about MSK Kids patient Rihanna, who was born with a cancer caused by an NTRK gene mutation and received the targeted therapy larotrectinib.

… Wednesday, September 7, 2022 The first day of kindergarten is a big day for every child’s family. But for Ana, it’s a day she worried would never come. Her daughter, Rihanna, has been a patient at Memorial Sloan Kettering Cancer Center (MSK) since she was a baby. Her groundbreaking treatment made history

… Friday, March 20, 2026 Student Research Six students make the transition from students to scientists as they begin their dissertation research. Eric Alonzo Eric Alonzo — Elucidating the role of PLZF in gd T cell development Our lab has recently shown that the Promyelocytic Leukemia Zinc Finger (PLZF)

American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such cancers is a viable approach.

… Thursday, August 31, 2017 VIDEO | 02:27 Active Monitoring of Papillary Thyroid Cancer American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such

Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.

… Thursday, November 21, 2024 On November 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to the drug zanidatamab (Ziihera ® ) to treat advanced and metastatic bile duct cancer (cholangiocarcinoma) and other biliary tract cancers that have high levels of a protein called HER2

Since its founding 19 years ago, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences has attracted bright minds drawn to its connection to MSK. Learn more about how we're training tomorrow's leaders.

… Wednesday, November 12, 2025 It’s that time of year, when aspiring scientists across the nation and the world are deciding where to pursue their doctoral degrees in biomedical research. The competition is intense, and the decision is a major life commitment. The PhD, or Doctorate of Philosophy, is the

Memorial Sloan Kettering has convened a COVID-19 Operating Room Executive Committee to scrutinize all surgical cases and determine whether they were truly essential and to review needs, resources, and ICU availability.

… Monday, May 11, 2020 The COVID-19 pandemic has stressed healthcare systems globally and is presenting particular challenges to cancer surgeons and cancer surgery programs. As New York City quickly became the epicenter of the pandemic in the United States, Memorial Sloan Kettering convened an Operating

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

… Wednesday, February 21, 2018 Summary In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to new targeted therapies. Last month, the US Food and Drug Administration